Anteis

Meyrin, Switzerland Founded: 2003 • Age: 23 yrs Acquired By Merz
Biopolymer-based injectable medical devices are developed for aesthetics and surgery.
Request Access

About Anteis

Anteis develops biopolymer injectables and injection technologies based on biopolymer transformation. The companys products consist mainly of medical devices for Aesthetic medicine such as wrinkle fillers, body contouring, skin rehydration products; Surgical ophthalmology i.e. products for cataract and glaucoma surgery; and Orthopedics Rheumatology, for example, viscoantalgics for osteoarthritis. Anteis has 2 factories located in Switzerland, and distributes its products through an international distributors network among more than 90 countries including Europe, Brazil, Japan and USA. Anteis was acquired by Merz Pharma in 2013 from previous owners, the private equity investor Signet Healthcare Partners.

  • Headquarter Meyrin, Switzerland
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Merz

    (Nov 08, 2013)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Anteis

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Anteis

Anteis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Merz. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Merz is recognized as a leader in aesthetic medicine and neurotoxin therapy.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Anteis

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Anteis

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Anteis Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Anteis

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Anteis

Frequently Asked Questions about Anteis

When was Anteis founded?

Anteis was founded in 2003.

Where is Anteis located?

Anteis is headquartered in Meyrin, Switzerland. It is registered at Meyrin, Geneva, Switzerland.

What does Anteis do?

Anteis develops biopolymer injectables and injection technologies based on biopolymer transformation. The companys products consist mainly of medical devices for Aesthetic medicine such as wrinkle fillers, body contouring, skin rehydration products; Surgical ophthalmology i.e. products for cataract and glaucoma surgery; and Orthopedics Rheumatology, for example, viscoantalgics for osteoarthritis. Anteis has 2 factories located in Switzerland, and distributes its products through an international distributors network among more than 90 countries including Europe, Brazil, Japan and USA. Anteis was acquired by Merz Pharma in 2013 from previous owners, the private equity investor Signet Healthcare Partners.

Who are Anteis's investors?

Anteis has 1 investor. Key investors include Merz.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available